Redaporfin
Redaporfin (LUZ11) acts as a potent photosensitizer. Redaporfin causes direct antineoplastic effects as well as indirect immune-dependent destruction of malignant lesions[1].
Product Specifications
CAS Number
1224104-08-8
Product Name Alternative
LUZ11; F2BMet
UNSPSC
12352005
Target
Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/redaporfin.html
Purity
99.44
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=S(C1=CC=C(F)C(/C2=C3CCC(/C(C4=C(F)C(S(=O)(NC)=O)=CC=C4F)=C5C=C/C(N/5)=C(C6=C(F)C(S(=O)(NC)=O)=CC=C6F)/C(CC/7)=NC7=C(C8=C(F)C(S(=O)(NC)=O)=CC=C8F)/C9=CC=C2N9)=N\3)=C1F)(NC)=O
Molecular Formula
C48H38F8N8O8S4
Molecular Weight
1135.11
References & Citations
[1]Lígia C Gomes-da-Silva, et al. Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus. EMBO J. 2018 Jul 2;37 (13) :e98354.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC140396-500 1x 500 µL
Ep-CAM / CD326 (323/A3), CF514 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC400608 20 µg
alpha smooth muscle Actin (ACTA2) (NM_001613) Human Over-expression Lysate
Sign In for Pricing
View Details